Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00050024 |
Recruitment Status :
Completed
First Posted : November 20, 2002
Last Update Posted : July 2, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study will use transcranial magnetic stimulation (TMS) and electrical stimulation of nerves to examine how the brain controls muscle movement in focal hand dystonia (writer's cramp). Normally, when a person moves a finger, the brain's motor cortex prevents the other fingers from moving involuntarily. Patients with focal hand dystonia have difficulty with individualized finger movements, possibly due to increased excitability of the motor cortex. Musicians, writers, typists, athletes and others whose work involves frequent repetitive movements may develop focal dystonia of the hand.
Healthy normal volunteers and patients with focal dystonia 18 years of age and older may be eligible for this study.
For the TMS procedure, subjects are seated in a comfortable chair with their hands placed on a pillow on their lap. An insulated wire coil is placed on the scalp. A brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the brain. This may cause muscle, hand or arm twitching if the coil is near the part of the brain that controls movement, or it may induce twitches or transient tingling in the forearm, head or face muscles. Subjects will be asked to move a finger. Just before this movement, a brief electrical stimulation will be applied to the end of either the second or fifth finger. Metal electrodes will be taped to the skin over the muscle for computer recording of the electrical activity of the hand and arm muscles activated by the stimulation. The testing will last 2-3 hours.
...
Condition or disease |
---|
Dystonic Disorders |
Study Type : | Observational |
Enrollment : | 38 participants |
Official Title: | The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia |
Study Start Date : | November 13, 2002 |
Study Completion Date : | September 17, 2008 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Nineteen patients age 18 and over with focal dystonia of the upper limbs (writer's cramp) will be recruited for the study.
For patients, the only selection criteria are the presence of focal hand dystonia.
Nineteen normal subjects age 18 and over will be recruited for the control group.
The controls will not have dystonia or any other neurological condition.
All subjects will sign an informed consent prior to participation in the trial.
EXCLUSION CRITERIA:
Exclusion criteria for the trial covering both the normal control and dystonia group will include any concurrent medical or surgical condition as well as neurological or psychiatric illnesses.
Exclusion criteria will include any individual who is on medications with potential influence of the nervous system function (antidepressants, anxiolytics, anticonvulsants, antipsychotic, antiparkinson, hypnotics, stimulants, and antihistamines).
The exclusion criteria also include patients who have received Botulinum toxin injection within 3 months of starting the protocol.
Furthermore, any individual who has a pacemaker, an implanted medical pump, a metal plate or metal object in the skull or eye (for example, after brain surgery), or who has a history of seizure disorder will be excluded from the trial.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00050024
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | |
Bethesda, Maryland, United States, 20892 |
ClinicalTrials.gov Identifier: | NCT00050024 |
Other Study ID Numbers: |
030048 03-N-0048 |
First Posted: | November 20, 2002 Key Record Dates |
Last Update Posted: | July 2, 2017 |
Last Verified: | September 17, 2008 |
TMS Afferent Stimulation Motor Cortex Writer's Cramp |
Surround Inhibition Heterotopic Inhibition Focal Dystonia Writer Cramp |
Dystonia Dystonic Disorders Dyskinesias Neurologic Manifestations |
Nervous System Diseases Movement Disorders Central Nervous System Diseases |